ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Court Orders Selikoff to Release Data Tapes To Tobacco Companies

August 25, 1989

To Become Effective Lobbyists, Scientists Seek Alliances With Patient Advocates

March 31, 1995

NIH Challenge Grant Announcement

March 6, 2009

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982

Two New Communications Contracts Approved

October 18, 1985

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982